Safety Profile of the New 5-ASA Based Compounds
5-aminosalicylic acid (5-ASA) preparations were anticipated to be and generally are better tolerated than sulphasalazine. Minor side effects such as headache, dizziness, abdominal pain and nausea do occur but are not more frequent than in placebo-treated patients. Approximately 10% of patients thoug...
Saved in:
Main Author: | Vinod K Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1990-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1990/345274 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapy of Inflammatory Bowel Disease using New 5-ASA Compounds: An Introduction
by: Ulrich Klotz
Published: (1989-01-01) -
Gut Toxicity of 5-ASA?
by: Desmond J Leddin, et al.
Published: (1993-01-01) -
Role of 5-ASA in IBD Therapy
by: CN Williams
Published: (1994-01-01) -
5-ASA Suppositories in Hemorrhoidal Disease
by: P Gionchetti, et al.
Published: (1992-01-01) -
Overview of 5-ASA in Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1994-01-01)